200
Participants
Start Date
February 20, 2025
Primary Completion Date
April 30, 2031
Study Completion Date
April 30, 2031
GORE® TAG® Thoracic Branch Endoprosthesis
Patients presenting with thoracic vascular disease that may benefit from the placement of TBE device. The target registry population is patients who are treated with TBE at participating sites. TBE treatment is qualified as receiving the TBE aortic component, at a minimum.
RECRUITING
Rigshospitalet University Hospital, Copenhagen
ACTIVE_NOT_RECRUITING
Laiko General hospital of Athens, Athens
RECRUITING
IRCCS Ospedale Policlinico San Martino, Genova
NOT_YET_RECRUITING
Universitätsklinikum Schleswig-Holstein, Kiel
RECRUITING
ASST Spedali Civili di Brescia, Brescia
NOT_YET_RECRUITING
AOU Padova, Padua
WITHDRAWN
Complejo Hospitalario Universitario de Vigo, Vigo
ACTIVE_NOT_RECRUITING
Policlinico di Sant'Orsola, Bologna
ACTIVE_NOT_RECRUITING
Universitätsklinikum Münster, Münster
ACTIVE_NOT_RECRUITING
Hospital Universitario Miguel Servet, Zaragoza
ACTIVE_NOT_RECRUITING
University of Heidelberg, Heidelberg
RECRUITING
Medizinische Universität Wien, Vienna
SUSPENDED
Universitätsklinikum Carl Gustav Carus Dresden, Dresden
RECRUITING
Evangelismos General Hospital, Athens
NOT_YET_RECRUITING
"Azienda Ospedaliera G. Brotzu", Selargius
RECRUITING
Amsterdam UMC, Amsterdam
RECRUITING
Radboud UMC, Nijmegen
ACTIVE_NOT_RECRUITING
Skane University Hospital, Malmo
NOT_YET_RECRUITING
St Thomas' Hospital, London
NOT_YET_RECRUITING
St Mary's Hospital, London
W.L.Gore & Associates
INDUSTRY